| Disease | myelodysplastic syndrome |
| Symptom | C0008625|chromosomal abnormality |
| Sentences | 1 |
| PubMedID- 25897259 | The fda label highlights particular issues in using revlimid® for myelodysplastic syndrome patients with a particular chromosomal abnormality (eg, del 5q). |
Page: 1